News

AI tools that detect ARIA on brain MRI in patients receiving anti-amyloid therapy for Alzheimer disease now have enough evidence behind them for clinical use, as long as the radiologist keeps ownership of the report. That is the conclusion of a multidisciplinary panel of neuroradiologists and Alzheimer disease clinicians, published September 16 in the American Journal of Roentgenology (AJR).

New research highlighted by the San Antonio Center for AD/ADRD Population Aging and Social Studies (CAPAS) suggests that vision problems following a stroke may also have important implications for brain health. Stroke survivors with vision impairment were found to have 2.3 times higher odds of developing dementia compared with stroke survivors who did not experience vision-related issues.

AAIC 2026 reminds us why this work matters far beyond the conference halls. Every poster, panel, and conversation in London traces back to the Duke-UNC ADRC’s core mission: advancing the science of Alzheimer’s disease and related dementias, translating discoveries into better care, supporting families navigating a dementia diagnosis, and promoting brain health equitably across the diverse communities we serve.

Heather Whitson’s new research into lucidity asks a profound question: if a dementia patient returns to clarity, were those capabilities ever truly gone?

A new study led by Duke/UNC ADRC Core Leader Andy Liu examined outcomes among 230 patients treated with lecanemab for early Alzheimer’s disease. The findings provide valuable real-world information about treatment safety, side effects, and patient monitoring as disease-modifying therapies become more widely available.

A long-term study of more than 12,000 adults found that people who maintained normal blood pressure, avoided diabetes, and did not smoke lived nearly 13 more years without dementia than those with all three risk factors. The findings support a growing body of evidence linking cardiovascular health to cognitive aging and dementia prevention.